Vanda Pharmaceuticals
VNDA
$4.75
Share price
2.81%
Change (1 day)
-22.64%
Change (1 year)
Categories
EPS for Vanda Pharmaceuticals (VNDA)
EPS in 2023 (TTM): $0.27
According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.27. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.60.
EPS history for Vanda Pharmaceuticals from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.27 | 125% |
| 2022 | $0.12 | -80% |
| 2021 | $0.60 | 39.53% |
| 2020 | $0.43 | -80.18% |
| 2019 | $2.17 | 334% |
| 2018 | $0.50 | -247.06% |
| 2017 | -$0.34 | -19.05% |
| 2016 | -$0.42 | -55.32% |
| 2015 | -$0.94 | -347.37% |
| 2014 | $0.38 | -156.72% |
| 2013 | -$0.67 | -31.63% |
| 2012 | -$0.98 | 172.22% |
| 2011 | -$0.36 | -238.46% |
| 2010 | $0.26 | -119.7% |
| 2009 | -$1.32 | -31.61% |
| 2008 | -$1.93 | -31.32% |
| 2007 | -$2.81 | -99.27% |
| 2006 | -$387.52 | 36045.14% |
| 2005 | -$1.07 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 5,116.78% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 1,285.19% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | 588.89% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 1,910.85% | 🇺🇸 USA |
 Merck MRK | $1.82 | 574.70% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 1,370.37% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | -$0.57 | -311.11% | 🇺🇸 USA |